MURAL ONCOLOGY PLC news, videos and press releases
For more news please use our advanced search feature.
MURAL ONCOLOGY PLC - More news...
MURAL ONCOLOGY PLC - More news...
- Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
- Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
- Mural Oncology to Participate in Two Upcoming Investor Conferences
- Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
- Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
- Mural Oncology to Host First Virtual Investor Day on September 26, 2024
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology to Present at Two Upcoming Investor Conferences
- Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
- Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
- Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
